Infectious Diseases and Global Health

Basic definition of infection refers to the harm caused by a foreign particle entering the host body. Some are mild and few are life-threatening depending on the type of organism causing it. Starting from the cause, symptoms, detecting the organism, clinical studies, treatment, controlling it before spreading, preventing the infection, developing new methods and techniques for diagnosis to developing new drugs and treatment strategies, you can discuss at our Euro Infectious Diseases 2020 The global market for infectious disease treatments is a result of the growth in demand for new pharmaceutical treatments, vaccines development, and environmental products. In 2017, the global market for the treatment of infectious disease totaled $64.8 billion. The market should total $99 billion by 2022, growing at a CAGR of 8.9% from 2017 to 2022.

Market Analysis: The infectious diseases and global health market is a dynamic and expanding sector, primarily driven by the rising prevalence of infectious diseases, increasing antimicrobial resistance, and significant technological advancements. The market is broadly segmented into therapeutics (drugs and vaccines) and diagnostics. The therapeutics market, valued at around $124 billion to $243 billion, is dominated by viral infections and is projected to grow steadily, with North America holding the largest share due to its robust healthcare infrastructure and high R&D investment. Simultaneously, the infectious disease diagnostics market, valued at approximately $25 billion, is also seeing robust growth driven by the demand for rapid and accurate testing, particularly at the point of care. The overall market is shaped by global health priorities, including pandemic preparedness, and is increasingly leveraging digital health technologies like telemedicine and AI to improve disease surveillance, diagnosis, and patient care, with the global digital health market alone projected to reach over $1.5 trillion by 2032. For more details:

Infectious Diseases and Global Health

Basic definition of infection refers to the harm caused by a foreign particle entering the host body. Some are mild and few are life-threatening depending on the type of organism causing it. Starting from the cause, symptoms, detecting the organism, clinical studies, treatment, controlling it before spreading, preventing the infection, developing new methods and techniques for diagnosis to developing new drugs and treatment strategies, you can discuss at our Euro Infectious Diseases 2020 The global market for infectious disease treatments is a result of the growth in demand for new pharmaceutical treatments, vaccines development, and environmental products. In 2017, the global market for the treatment of infectious disease totaled $64.8 billion. The market should total $99 billion by 2022, growing at a CAGR of 8.9% from 2017 to 2022.

Market Analysis: The infectious diseases and global health market is a dynamic and expanding sector, primarily driven by the rising prevalence of infectious diseases, increasing antimicrobial resistance, and significant technological advancements. The market is broadly segmented into therapeutics (drugs and vaccines) and diagnostics. The therapeutics market, valued at around $124 billion to $243 billion, is dominated by viral infections and is projected to grow steadily, with North America holding the largest share due to its robust healthcare infrastructure and high R&D investment. Simultaneously, the infectious disease diagnostics market, valued at approximately $25 billion, is also seeing robust growth driven by the demand for rapid and accurate testing, particularly at the point of care. The overall market is shaped by global health priorities, including pandemic preparedness, and is increasingly leveraging digital health technologies like telemedicine and AI to improve disease surveillance, diagnosis, and patient care, with the global digital health market alone projected to reach over $1.5 trillion by 2032. For more details: